Characterization of Brca1 deficient mice

Breast Disease

Volumn 10, Issue 1-2, 1998, Pages 33-44

  Snouwaert, John N ^a   Gowen, Lori C ^a,b   Lee, Victoria ^a,b   Koller, Beverly H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

BLASTOCYST; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CELL LINE; GENE MUTATION; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0031944670     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/BD-1998-101-206     Document Type: Review

References (31)

1. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene Brca1. Science 1994; 266:66-71.
2. Futreal PA, Liu Q, Shattuck-Eidens D, et al. BRCA1 Mutations in Primary Breast and Ovarian Carcinomas. Science 1994; 266:120-122.
3. Freidman LS, Ostermeyer EA, Szabo CI, et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994; 8:399-404.
4. Gowen L, Johnson BL, Latour AM, et al. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 1996; 12:191-194.
5. Hakem R, de la Pompa JL, Sirard C, et al. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 1990; 85:1009-1023.
6. Liu C-Y, Flesken-Nikitin A, Li S, et al. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev 1996; 10:1835-1843.
7. Ludwig T, Chapman DL, Papaioannou VE, et al. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev 1997; 11:1226-1241.
8. 5-6 early embryonic lethality by p53 or p21 null mutation. Nat Genet 1997; 16:298-302.
9. Abel KJ, Xu J, Yin G-Y, et al. Mouse Brca1: localization sequence analysis and identification of evolutionary conserved domains. Hum Mol Genet 1995; 4:2265-2273.
10. Bennet LM, Haugen-Strano A, Cochran C, et al. Isolation of the mouse homologue of Brca1 and genetic mapping to mouse chromosome 11. Genomics 1995; 29:576-581.
11. Sharan SK, Wims M, Bradley A. Murine Brca1: sequence and significance for human missense mutations. Hum Mol Genet 1995; 4:2275-2278.
12. Brown MA, Xu C-F, Nicolai H, et al. The 5' end of the Brca1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 1997; 12:2507-2513.
13. Chambers JA, Solomon E. Isolation of the Murine NBr1 Gene Adjacent to the Murine Brca1 gene. Genomics 1996; 38:305-313.
14. Lane TF, Deng C, Elson A, et al. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 1995; 9:2712-2722.
15. Casstilla LH, Couch FJ, Erdos MR, et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 1994; 8:387-391.
16. Lovering R, Hanson IM, Borden KLB, et al. Identification and preliminary characterization of a protein motif related to the zinc finger. Proc Natl Acad Sci USA 1993; 90:2112-2116.
17. Chapman MS, Verma IM. Transcriptional activation by BRCA1. Nature 1996; 382:678-679.
18. Monteiro ANA, August A, Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci USA 1996; 93:13595-13599.
19. Callebaut I, Mornon J-P. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett 1997; 400:25-30.
20. Chen Y, Farmer AA, Chen C-F, et al. BRCA1 is a 220-kda nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 1996; 56:3168-3172.
21. Zhang HT, Zhang X, Zhao HZ, et al. Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene 1997; 14:2863-2869.
22. Scully R, Chen J, Ochs RL, et al. Dynamic Changes of BRCA1 Subnuclear Localization and Phosphorylation State Are Initiated by DNA Damage. Cell 1997; 90:425-435.
23. Scully R, Chen J, Plug A, et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997; 88:265-275.
24. Scully R, Anderson SF, Chao DM, et al. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci USA 1997; 94:5605-5610.
25. Marquis ST, Rajan JV, Wynshaw-Boris A, et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 1995; 11:17-26.
26. Gudas JM, Li T, Nguyen H, et al. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ 1996; 7:717-723.
27. Boyd M, Harris F, McFarlane R, et al. A human BRCA1 gene knockout. Nature 1995; 375:541-542.
28. Jones SN, Roe AE, Donehower LA, et al. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 1995; 378:206-208.
29. Montes de Oca Luna R, Wagner DS, Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995; 378:203-206.
30. Xiong Y, Hannon GJ, Zhang H, et al. p21 is a universal inhibitor of cyclin kinases. Nature 1995; 366:701-704.
31. Somasundaram K, Zhang H, Zeng Y-X, et al. Arrest of the cell cycle by the tumor-suppressor BRCA1 requires the CDK-inhibitor p21waf1/CiPl. Nature 1997; 389:187-190.